A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Turning off the genetic switch to its respiratory system might finally eliminate the bacteria behind tuberculosis.

Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...